Steven J. Bernstein, MD, MPH


5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

July 11, 2018

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.

Diabetes Care Improvement in Pharmacist- Versus Nurse-Supported Patient-Centered Medical Homes

November 22, 2017

In this longitudinal comparative effectiveness study of different chronic disease self-management support approaches within 1 system, both pharmacist- and nurse-led patient-centered medical home approaches improved diabetes care.